Apogee Therapeutics, Inc. ($APGE)
Filing Information
| Accession Number | 0001104659-26-002574 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 10, 2026 |
| Document Date | Jan 7, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
46,750
Total Value
$1,776,224.56
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jan 7, 2026 | Exercise/Conversion | 14,025 | $22.86 | $320,611.50 | 231,223 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 7, 2026 | Sale | 2,954 | $77.13 | $227,842.02 | 228,269 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 7, 2026 | Sale | 14,820 | $77.90 | $1,154,478.00 | 213,449 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 7, 2026 | Sale | 826 | $79.04 | $65,287.04 | 212,623 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 7, 2026 | Sale | 100 | $80.06 | $8,006.00 | 212,523 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Jan 7, 2026 | Exercise/Conversion | 14,025 | $0.00 | $0.00 | 139,540 | Direct | โ | View Details |